Texas

Start Pallas's online intake — it takes about 5 minutes and covers your health history, goals, and current medications. A Texas-licensed clinician reviews it, and because Texas allows asynchronous-first care for non-controlled medications like GLP-1s, that review can happen by secure message without a scheduled video call, unless your history calls for one — out-of-state licensure is never sufficient, so every clinician who treats you holds an active Texas medical license. If a GLP-1 is clinically appropriate, your clinician prescribes it, and a US-licensed pharmacy ships your medication to any Texas address in 2–3 business days.

The process is the same as for semaglutide — complete Pallas's online intake, and a Texas-licensed clinician reviews it, asynchronously in most cases, since Texas allows telehealth providers to establish care and prescribe without a live video visit when the standard of care is met. If appropriate, your clinician can prescribe compounded tirzepatide, prepared per-patient by a U.S. state-licensed §503A compounding pharmacy when there is a documented clinical need, or an FDA-approved brand-name option like Zepbound^® or Mounjaro^®, through the same intake. These are distinct products with different regulatory status; your clinician will explain which fits you.

Yes — compounded semaglutide is available to eligible Texas residents through licensed telehealth. It is prepared per-patient by US-licensed compounding pharmacies under FDCA §503A, and a Texas-licensed clinician must prescribe it based on a documented, patient-specific clinical rationale. Pallas serves Texas with free shipping. FDA-approved brand-name options like Wegovy^® and Zepbound^® are also available through the same intake.

Yes. Texas licenses nurse practitioners to prescribe non-controlled medications like semaglutide and tirzepatide under a Prescriptive Authority Agreement — a written delegation arrangement with a Texas-licensed physician required by the Texas Occupations Code. Because GLP-1s are not controlled substances, Texas also allows the provider-patient relationship to be established entirely through telehealth, with no in-person visit required. Every Pallas clinician who treats Texas patients holds an active Texas license and prescribes within these rules.

Several licensed telehealth platforms serve Texas residents seeking compounded semaglutide. Before choosing one, verify that its clinicians are licensed in Texas, that it works with US-licensed §503A compounding pharmacies, and that it holds LegitScript Healthcare Merchant Certification — you can check any platform's certification status in LegitScript's public database. Pallas serves Texas residents and is LegitScript Healthcare Merchant Certified.

No — Texas allows a licensed provider to establish the provider-patient relationship and prescribe non-controlled medications like semaglutide through telehealth, including asynchronous review of your intake. Most Texas patients complete everything by secure message; a provider may request a brief video visit only if your history calls for it.

Most Texas patients complete online intake in about five minutes, and a Texas-licensed clinician typically reviews it within 1–2 business days, since Texas allows asynchronous-first care with no mandatory video visit. If semaglutide is clinically appropriate, your prescription goes to a US-licensed pharmacy, which ships to any Texas address in 2–3 business days after filling. An incomplete intake, a missing ID or photo, or a clinician requesting a follow-up video visit can add time — there is no guaranteed timeline, since review depends on your individual history.

Yes — telehealth access through Pallas is the same across Texas, whether you're in Houston, San Antonio, Dallas, Austin, Fort Worth, or a smaller community in East Texas or near Texarkana. A Texas-licensed clinician reviews every intake the same way regardless of ZIP code, and licensed partner pharmacies ship both compounded medications and FDA-approved brands like Zepbound^® to any Texas address. Distance from a major metro does not change your eligibility or your care.

Several telehealth providers prescribe tirzepatide to Texas residents. Before choosing one, verify that its clinicians hold an active Texas medical license, that it works with US-licensed §503A compounding pharmacies (or offers FDA-approved Zepbound^®/Mounjaro^® as the brand-name option), and that it carries LegitScript Healthcare Merchant Certification — checkable in LegitScript's public database. Pallas serves Texas residents and is LegitScript Healthcare Merchant Certified.

Texas Medicaid covers certain GLP-1s for FDA-approved diabetes indications but does not cover GLP-1s prescribed for weight loss, and does not cover compounded GLP-1s. Pallas is a cash-pay telehealth service, so Medicaid rules do not govern our pricing.

Pallas is a cash-pay telehealth service — there is no insurance to bill. Your Pallas Membership covers your clinician's review, ongoing check-ins, and care-team messaging; the medication is billed separately and ships free to your Texas address, only when a clinician prescribes it. You see your full price during intake before you pay anything — no surprise renewal markups. The price is the same whether you are in Houston, Dallas, or a rural Texas ZIP code.

In general, adults with a BMI of 30 or higher, or a BMI of 27 or higher together with a weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnea, are considered for GLP-1 weight-management treatment. Eligibility is always decided by a Texas-licensed clinician after reviewing your full intake, never by an automated quiz. Your clinician also reviews your medical history and current medications to confirm a GLP-1 is appropriate and safe for you, and will tell you if it is not.

Brand-name medications — Wegovy^® and Ozempic^® (semaglutide) and Zepbound^® and Mounjaro^® (tirzepatide) — are FDA-approved products from their manufacturers, offered cash-pay. Compounded semaglutide and tirzepatide are prepared on a per-patient basis by US-licensed compounding pharmacies, regulated under federal law (FDCA §503A) and by state boards of pharmacy, when a clinician documents a patient-specific clinical need. While these pharmacies are highly regulated, the compounded medications themselves are not FDA-approved, are not generic versions of brand-name drugs, and have not been evaluated by the FDA for safety, efficacy, or quality. Which option fits you is a clinical decision you make with your Texas-licensed provider.

Yes, many patients transfer their care to Pallas. During intake you tell your clinician which medication and dose you take now and how you have tolerated it. Your Texas-licensed provider reviews that history and, if appropriate, continues you at a comparable dose or adjusts your titration plan. Do not stop or change a prescription on your own — let your clinician guide any transition.

Most patients use a once-weekly injection with a very fine needle, but a compounded oral semaglutide tablet is available for people who would rather not inject. Both are prescribed only after a clinician confirms they are appropriate for you, and your provider can help you weigh which form fits your routine and goals.

The most common side effects are gastrointestinal — nausea, constipation, diarrhea, or reflux — and they are usually mildest when the dose is raised slowly, which is why clinicians titrate up gradually. GLP-1s are not right for everyone; they are avoided in people with a personal or family history of medullary thyroid carcinoma or MEN2, and during pregnancy. Your Pallas clinician screens for these before prescribing and stays available to help you manage any side effects.

You complete a detailed online intake in under five minutes, sharing your health history, goals, and current medications. A clinician licensed by the Texas Medical Board reviews it asynchronously in most cases — no live video required — and may follow up by secure message or request labs if your history calls for it. If a GLP-1 is appropriate, your prescription goes to a licensed pharmacy that ships to any Texas address, usually within 2–3 business days.

Pallas care is ongoing, not a one-time script. Your plan renews on a regular cadence so your medication arrives before you run out, and your clinician schedules check-ins to monitor your response, adjust your dose, and manage side effects. You can message your care team, change your plan, or cancel anytime from your patient portal — no phone calls or retention hoops.

Compounded semaglutide injection through Pallas is $139 for your first month, then $597 every 12 weeks ($199/mo average). Cancel anytime. That one plan price includes your US-licensed provider, ongoing check-ins, dose adjustments, and unlimited care-team messaging — no separate membership fee. Medication ships free to any Texas address, only if a clinician prescribes it, and you are refunded in full if a clinician decides treatment isn't right for you.

Compounded tirzepatide injection through Pallas is $179 for your first month, then $897 every 12 weeks ($299/mo average). Cancel anytime. That one plan price includes your US-licensed provider, ongoing check-ins, dose adjustments, and unlimited care-team messaging — no separate membership fee. Medication ships free to any Texas address, only if a clinician prescribes it, and you are refunded in full if a clinician decides treatment isn't right for you.

Yes. FDA-approved Wegovy^® and Zepbound^® for chronic weight management — plus Ozempic^® and Mounjaro^® for type 2 diabetes — are available to Texas patients cash-pay from $1069/mo; insurance is not billed. Whether a brand-name or compounded medication is appropriate for you is determined by a clinician licensed in Texas during intake.

No — Medicaid does not currently cover GLP-1 medications for weight loss. Texas Medicaid covers GLP-1s like semaglutide for type 2 diabetes but does not cover GLP-1s prescribed primarily for weight loss. Compounded GLP-1s are not covered. Pallas is a cash-pay telehealth service — we do not bill Medicaid or private insurance. Pricing is flat and disclosed up front; the cost questions on this page carry current plan terms.

Losing coverage doesn't have to interrupt treatment. Pallas is cash-pay — no insurance required — with two paths in Texas: staying on FDA-approved brand-name Wegovy^® or Zepbound^® at flat cash-pay pricing from $1069/mo, or, when a clinician licensed in Texas determines it is clinically appropriate for you, a compounded semaglutide or tirzepatide plan at a lower price point (current terms are in the cost questions on this page). During intake, tell your clinician what you are taking now and your current dose — they factor that history into your treatment plan and starting dose. Our guide to switching GLP-1 telehealth providers on the Pallas blog covers records, timing, and what to expect.

That is a decision you make with your clinician. Semaglutide activates the GLP-1 receptor; tirzepatide activates both the GLP-1 and GIP receptors. In the SURMOUNT-5 head-to-head trial of the FDA-approved products, Zepbound^® (tirzepatide 10 mg or 15 mg weekly) produced greater average weight loss than Wegovy^® (semaglutide 1.7 mg or 2.4 mg weekly) — 20.2% versus 13.7% of body weight over 72 weeks. Wegovy^®'s maximum dose is now 7.2 mg weekly, which was not studied in SURMOUNT-5; in the separate STEP UP trial it reached 18.7% average weight loss over 72 weeks. Clinical trial outcomes for the FDA-approved products have not been established for compounded preparations. Individual results vary. Semaglutide plans cost less and semaglutide has the longer post-market record; a clinician licensed in Texas weighs your history, goals, and budget to recommend a starting point.